Current Pharmaceuticals News Today
NPS Pharmaceuticals to Report 2011 Financial Results
NPS Pharmaceuticals, Inc. announced today that it will report its 2011 financial results on Wednesday, February 15, 2012 at approximately 4:30 p.m. ET. The press release will be followed by a conference call and webcast at 5:00 p.m.
Wed, 08 Feb 2012 13:10:00 -0800
Watson Reaches Settlement With Janssen Pharmaceuticals, Inc. Over ORTHO TRI-CYCLEN(R) LO
PARSIPPANY, N.J., Feb. 8, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - News) today announced that its subsidiary, Watson Laboratories, Inc., has reached a settlement with Janssen Pharmaceuticals, ...
Wed, 08 Feb 2012 05:30:00 -0800
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
Ironwood Pharmaceuticals, Inc. announced today that it has commenced an underwritten public offering of 5,250,000 shares of its Class A common stock. All of the shares are being offered by Ironwood.
Wed, 08 Feb 2012 13:57:00 -0800
Spectrum Pharmaceuticals to Present at the BIO CEO Investor Conference
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the BIO CEO Investor Conference, being held at the Waldorf=Astoria Hotel in New York City.
Tue, 07 Feb 2012 04:00:00 -0800
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States.
Tue, 07 Feb 2012 22:01:00 -0800
|
